DANTROLENE for Hyperthermia malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 29 adverse event reports in the FDA FAERS database where DANTROLENE was used for Hyperthermia malignant.
Most Reported Side Effects for DANTROLENE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 74 | 24.8% | 15 | 42 |
| Neuroleptic malignant syndrome | 50 | 16.8% | 12 | 41 |
| Off label use | 30 | 10.1% | 3 | 19 |
| Respiratory failure | 20 | 6.7% | 9 | 10 |
| Drug ineffective for unapproved indication | 18 | 6.0% | 2 | 13 |
| Nausea | 17 | 5.7% | 0 | 14 |
| Dizziness | 15 | 5.0% | 0 | 13 |
| Pyrexia | 15 | 5.0% | 1 | 13 |
| Asthenia | 14 | 4.7% | 0 | 9 |
| Decreased appetite | 14 | 4.7% | 0 | 13 |
| Product use issue | 14 | 4.7% | 2 | 3 |
| Rhabdomyolysis | 14 | 4.7% | 5 | 14 |
| Weight decreased | 13 | 4.4% | 0 | 13 |
| Drug prescribing error | 12 | 4.0% | 0 | 12 |
| Condition aggravated | 11 | 3.7% | 0 | 7 |
Other Indications for DANTROLENE
Product used for unknown indication (89)
Neuroleptic malignant syndrome (44)
Muscle spasms (17)
Dystonia (13)
Cerebral vasoconstriction (6)
Muscle spasticity (6)
Hyperthermia (5)
Rhabdomyolysis (5)
Tardive dyskinesia (5)